Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Capitalinc Investment Tbk. (MTFN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Capitalinc Investment Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Capitalinc Investment Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Capitalinc Investment Tbk. trades at Rp13 (market cap 413.95B, 21.34M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Capitalinc Investment Tbk. is far larger — about 2.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Capitalinc Investment Tbk. is more actively traded (21.34M versus 324K). Which is the better fit depends on your goals.

MTFNOBAT
Market Cap
413.95B166.01B
Volume
21.34M324K
Lot
213.43K3.24K
Turnover
77.68M
Average Price
239.75
Value
77.68M
Indicative Equilibrium Price
240
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MTFN
View details
OBAT
View details

About Capitalinc Investment Tbk.

PT Capitalinc Investment Tbk formerly PT Bakrie Finance Corporation Tbk hereinafter called the Company was established based on deed No.15 dated November 11, 1993 of Notary Soedarno, SH. The deed of establishment was approved by the Minister of Justice of the Republic of Indonesia in his decree No. C2.7999-HT.01.01.Th.83 dated December 12, 1983 and was published in the State Gazette of the Republic of Indonesia No.4 dated January 13, 1984, Supplement No.35.Before the amendment in its articles of association, the scope of its activities include leasing, factoring receivable and consumer financing. The Company obtained its operating license as a financial institution from the Minister of Finance of the Republic of Indonesia through decree No.295/KMK.013/1990 dated March 3, 1990. In line with the change in the Company’s scope of activities, the Company’s financing activities have been transferred to PT Swadinamika Bakrie Finance, a subsidiary.

Read more on MTFN

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT